Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZTREONAM Cause Type iv hypersensitivity reaction? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Type iv hypersensitivity reaction have been filed in association with AZTREONAM (AZACTAM). This represents 0.3% of all adverse event reports for AZTREONAM.

6
Reports of Type iv hypersensitivity reaction with AZTREONAM
0.3%
of all AZTREONAM reports
0
Deaths
4
Hospitalizations

How Dangerous Is Type iv hypersensitivity reaction From AZTREONAM?

Of the 6 reports, 4 (66.7%) required hospitalization, and 2 (33.3%) were considered life-threatening.

Is Type iv hypersensitivity reaction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZTREONAM. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does AZTREONAM Cause?

Off label use (195) Dyspnoea (184) Eosinophilia (161) Cough (123) Drug hypersensitivity (116) Pyrexia (107) Wheezing (103) Infective pulmonary exacerbation of cystic fibrosis (99) Asthma (94) Rash (82)

What Other Drugs Cause Type iv hypersensitivity reaction?

AMOXICILLIN (165) CLINDAMYCIN (128) INFLIXIMAB (120) CEFACLOR (101) IBUPROFEN (98) AMPICILLIN (97) VANCOMYCIN (97) CEPHALEXIN (92) AMOXICILLIN\CLAVULANIC ACID (89) CEFUROXIME (82)

Which AZTREONAM Alternatives Have Lower Type iv hypersensitivity reaction Risk?

AZTREONAM vs AZTREONAM LYSINE AZTREONAM vs BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN AZTREONAM vs BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN AZTREONAM vs BACITRACIN AZTREONAM vs BACITRACIN\NEOMYCIN\POLYMYXIN B

Related Pages

AZTREONAM Full Profile All Type iv hypersensitivity reaction Reports All Drugs Causing Type iv hypersensitivity reaction AZTREONAM Demographics